- Medicover
- Medical consultation
- For adults
- Qualification for the EndoRNA test
Qualification for the EndoRNA test
The EndoRNA test is an innovative test that allows you to quickly diagnose endometriosis. A gynaecologist can qualify you for the EndoRNA test with the possibility of performing the test during one visit. There is a short waiting time for results – about 2-3 weeks.
The price includes all fees
Lowest price from 30 days before discounting PLN 285.00Qualification for the EndoRNA test
Did you know that according to WHO data, as many as 1 in 10 women of childbearing age may struggle with endometriosis?
The EndoRNA test is for women who have:
-
pain that adversely affects every day functioning (e.g. pain during menstruation, intercourse, urination or defecation, pain in the sacral area),
-
chronic nausea, constipation, diarrhoea,
-
suspicion of endometriosis,
-
a long-term problem with getting pregnant.
Untreated endometriosis can even lead to infertility. It is estimated that about 35% of patients who have problems getting pregnant have already been diagnosed with endometriosis, have suspected endometriosis or were diagnosed with this disease while looking for causes of infertility. That is why it is so important to diagnose the disease quickly, especially in women planning pregnancy.
Benefits of performing the EndoRNA test:
-
potentially shortening the diagnostic process for infertility and pain,
-
saves time - qualification with the possibility of performing the EndoRNA test during one visit (the test and procedure are additionally payable),
-
safety and quick return to everyday activities - the EndoRNA test is minimally invasive,
-
short waiting time for results (about 2-3 weeks),
-
ability to discuss the results with the doctor during a telephone consultation.
What is involved in the qualification process for the EndoRNA test?
![]() |
During the qualification, the gynaecologist will:
|
If the patient is not qualified for the EndoRNA test, the cost of the qualifying visit is not refunded.
![]() |
NOTE! The patient should come for a visit in the second phase of the menstrual cycle, which is after ovulation and before menstruation. Please bring your current medical records with you to the appointment. |
How to book an appointment?
![]() |
After making the purchase in the online store, the coordinator from the selected Medical Centre will contact the patient within 2 business days to arrange a convenient date for the visit. If you have any questions, please contact our hotline at +48 500 900 505. |
![]() |
NOTE! The patient should come for a visit in the second phase of the menstrual cycle, which is after ovulation and before menstruation. Please bring your current medical records with you to the appointment. |
The sample cannot be taken from a pregnant woman.
The price of the qualifying visit does not include the cost of the EndoRNA test and the test procedure (sample collection). The cost of the EndoRNA test and the test procedure (sample collection): from 1 990 to 2 200 PLN depending on the city.
Test results
![]() |
The waiting time for results is about 2-3 weeks. Medicover will contact you to arrange a teleconsultation with a gynaecologist who will discuss the test results with the patient over the phone. |
Due to non-specific symptoms and a number of basic tests, the process of endometriosis diagnosis is usually very long, lasting even several years.
It is possible to shorten the diagnostic path by performing a minimally invasive EndoRNA qRT-PCR test. Endometriosis is a disease in which the tissue lining the uterus (endometrium) appears in other parts of the body, such as:
- ovaries and fallopian tubes,
- uterine muscle,
- vagina,
- bladder and ureters,
- rectum,
- peritoneal or retroperitoneal space.
The EndoRNA test is a medical device. For safety, use it according to the instructions or label. If in doubt, consult a specialist. The manufacturer of the test is Medicover Genetics.
Others also bought

Liquid-based cytology detects about 64% more high-risk lesions than conventional cytology and enables the early detection of human papillomavirus (HPV) infection – the virus that causes cervical cancer. Meanwhile, LBC with HPV-14 genotyping also makes it possible to determine the specific HPV type that can lead to cancer, making it easier to assess risk and increasing the chances of a complete cure.

A non-invasive test for women with a suspected diagnosis of endometriosis that is performed on a sample of venous blood taken from the patient.



